B-cell Depletion in Animal Models of Central Nervous System Diseases
Research on B-cell depletion in CNS disorders has increased, particularly focusing on multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). This work highlights that while there is a solid basis for B-cell studies in MS, overall evidence remains specific to certain diseases.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not yet tested in people
- Mechanism
- Not reported
- Evidence strength
- Early – laboratory or animal research
- Outcome
- Not reported
Results in cells or animals often do not carry over to people with MS.
Why it matters
The findings underline the importance of B-cell involvement in CNS diseases and set a foundation for future research. However, this knowledge is largely confined to the context of MS and its models.
What this does not prove
The literature primarily revolves around MS and experimental models, limiting broader applicability and understanding across other CNS diseases.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-19
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- CD20
- Pathway
- Not reported
- Population
- Articles related to central nervous system diseases from 2006 to August 2026.
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceB-Cell-Related Neuroinflammation Across Central Nervous System Diseases: A Bibliometric and Science-Mapping Analysis, 2006-2026. ↗DOI: 10.2147/jir.s635719
Supporting passages (10)
sample size basisarticles published
publication date2026-10-19
interventionB-cell depletion
findingsB-cell-related CNS research has expanded, but evidence maturity remains disease-specific. MS/EAE provides the clearest foundation.
limitationsThe literature remains centered on multiple sclerosis and its experimental models, especially studies of B-cell-depleting treatments and B-cell accumulation around the meninges.
biological targetsCD20
populationTitle: B-Cell-Related Neuroinflammation Across Central Nervous System Diseases: A Bibliometric and Science-Mapping Analysis, 2006-2026.
peer reviewedPublication types: Journal Article
subjectsCo-citation and keyword analyses showed an MS/experimental autoimmune encephalomyelitis (EAE)-centered foundation built around B-cell depletion trials, meningeal pathology, diagnostic criteria, and regulatory B-cell biology.
human efficacyCo-citation and keyword analyses showed an MS/experimental autoimmune encephalomyelitis (EAE)-centered foundation built around B-cell depletion trials, meningeal pathology, diagnostic criteria, and regulatory B-cell biology.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.